Qiong Wu

机构：The University of Texas MD Anderson Cancer Center, Zhengzhou University · ORCID：0009-0006-9223-2467

发表论文 102 篇 · 总被引 2180 次 · h-index 28

代表论文

• A sinomenine derivative alleviates bone destruction in collagen-induced arthritis mice by suppressing mitochondrial dysfunction and oxidative stress via the NRF2/HO-1/NQO1 signaling pathway (2025 · Pharmacological Research · 被引 38)
• Azathioprine Plus Exclusive Enteral Nutrition Versus Azathioprine Monotherapy for the Prevention of Postoperative Recurrence in Patients with Crohn’s Disease: An Open-Label, Single-Centre, Randomized Controlled Trial (2024 · Journal of Crohn s and Colitis · 被引 11)
• Nanomedicines Against Mitochondrial Dysfunction‐Induced Metabolic Diseases (2025 · Advanced Science · 被引 10)
• ELAVL1 regulates glycolysis in nasopharyngeal carcinoma cells through the HMGB3/β-catenin axis (2024 · Molecular Medicine · 被引 6)
• Development and validation of a simple-to-use nomogram for self-screening the risk of dyslipidemia (2023 · Scientific Reports · 被引 6)
• Biomineralized Cu-Disulfiram nanoparticles Potentiate Colorectal cancer immunotherapy through synergistic cuproptosis and apoptosis (2025 · Materials & Design · 被引 4)